[1]黄文森,孙志纯,李靖云,等.绝经后女性2型糖尿病患者血清趋化素和骨代谢标志物与骨密度的相关性及其对骨质疏松症的预测价值[J].新乡医学院学报,2022,39(11):1019-1024.[doi:10.7683/xxyxyxb.2022.11.004]
　HUANG Wensen,SUN Zhichun,LI Jingyun,et al.Correlation between serum chemerin,bone metabolic markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus and their predictive value for osteoporosis[J].Journal of Xinxiang Medical University,2022,39(11):1019-1024.[doi:10.7683/xxyxyxb.2022.11.004]
点击复制

绝经后女性2型糖尿病患者血清趋化素和骨代谢标志物与骨密度的相关性及其对骨质疏松症的预测价值
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年11
页码:
1019-1024
栏目:
临床研究
出版日期:
2022-11-05

文章信息/Info

Title:
Correlation between serum chemerin,bone metabolic markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus and their predictive value for osteoporosis
作者:
黄文森1; 2; 孙志纯2; 李靖云3; 洪真真2; 邓少雄1; 卓雅芬2; 陈丽云1; 2; 张翼2
（1.泉州医学高等专科学校内科学教研室，福建　泉州　362000；2.福建医科大学附属泉州第一医院内分泌科，福建　泉州　362000；3.泉州医学高等专科学校医学影像学教研室，福建　泉州　362000）
Author(s):
HUANG Wensen1; 2; SUN Zhichun2; LI Jingyun3; HONG Zhenzhen2; DENG Shaoxiong1; ZHUO Yafen2; CHEN Liyun1; 2; ZHANG Yi2
（1.Department of Internal Medicine,Quanzhou Medical College,Quanzhou 362000,Fujian Province,China;2.Department of Endocrinology,Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou 362000,Fujian Province,China;3.Department of Medical Imaging,Quanzhou Medical College,Quanzhou 362000,Fujian Province,China）
关键词:
绝经后女性; 2型糖尿病; 骨密度; 趋化素; 骨代谢标志物
Keywords:
postmenopausal women; type 2 diabetes mellitus; bone mineral density; chemerin; bone metabolic marker
分类号:
R587.2
DOI:
10.7683/xxyxyxb.2022.11.004
文献标志码:
A
摘要:
目的　探讨绝经后女性2型糖尿病（T2DM）患者血清趋化素及骨代谢标志物与骨密度的相关性及其对骨质疏松症的预测价值。方法　选择2019年9月至2021年6月福建医科大学附属泉州第一医院(泉州医学高等专科学校教学医院)内分泌科收治的321例绝经后女性T2DM患者为研究对象，采用双能Ｘ线骨密度仪检测腰椎、股骨颈及全股骨的骨密度T值，按照T值将患者分为骨量正常组（n=114）、骨量减少组（n=117）和骨质疏松症组（n=90）。比较3组患者的年龄、糖尿病病程、体质量指数（BMI）等临床资料；采用双抗体夹心酶联免疫吸附试验法定量检测3组患者血清趋化素水平，葡萄糖氧化酶法检测3组患者空腹血糖（FPG）水平，高压液相色谱法检测3组患者糖化血红蛋白(HbA1c)水平，电化学发光法检测3组患者血清C肽（FCP）、25-羟基维生素D［25(OH)D］、甲状旁腺激素（PTH）、总骨Ⅰ型前胶原N端肽（T-P1NP）、β-胶原特殊序列(β-CTX)水平；采用Pearson和多重线性回归分析腰椎、股骨颈及全股骨的骨密度与年龄、糖尿病病程、体质量指数（BMI）、血清趋化素及骨代谢标志物的相关性。结果　3组患者的FPG、FCP、HbA1c、PTH水平比较差异无统计学意义（F=0.414、0.699、0.190、1.651，P>0.05）。骨质疏松症组患者的年龄显著大于骨量减少组和骨量正常组，糖尿病病程显著长于骨量减少组和骨量正常组，T-P1NP、β-CTX、血清趋化素水平显著高于骨量减少组和骨量正常组，BMI、25(OH)D水平显著低于骨量减少组和骨量正常组（P<0.05）；骨量减少组患者的年龄大于骨量正常组，糖尿病病程显著长于骨量正常组，T-P1NP、β-CTX、血清趋化素水平显著高于骨量正常组，BMI、25(OH)D水平显著低于骨量正常组（P<0.05）。Pearson回归分析结果显示，腰椎骨密度与BMI、25(OH)D呈正相关（r=0.336、0.184，P<0.05），与年龄、T-P1NP、β-CTX、血清趋化素呈负相关（r=-0.594、-0.294、-0.489、-0.359，P<0.05）；股骨颈骨密度与BMI、25(OH)D呈正相关（r=0.313、0.228，P<0.05），与年龄、糖尿病病程、T-P1NP、β-CTX、血清趋化素呈负相关（r=-0.577、-0.178、-0.223、-0.378、-0.336，P<0.05）；全股骨骨密度与BMI、25(OH)D呈正相关（r=0.400、0.225，P<0.05），与年龄、糖尿病病程、T-P1NP、β-CTX、血清趋化素呈负相关（r=-0.487、-0.160、-0.235、-0.392、-0.373，P<0.05）。 多重线性回归分析显示，年龄、BMI、25(OH)D、T-P1NP、β-CTX是影响腰椎骨密度的因素（β=-0.010、0.013、0.005、-0.001、-0.274，P<0.05）；年龄、糖尿病病程、BMI、25(OH)D、β-CTX和血清趋化素是影响股骨颈骨密度的因素（β=-0.008、-0.003、0.012、0.005、-0.152、-0.001，P<0.05）；年龄、糖尿病病程、BMI、25(OH)D、β-CTX和血清趋化素是影响全股骨骨密度的因素（β=-0.008、-0.004、0.019、0.006、-0.152、-0.001，P<0.05）。结论　绝经后女性T2DM患者的骨密度随着年龄的增长和糖尿病病程的延长呈下降趋势，BMI是绝经后女性T2DM患者骨密度的保护性因素；血清趋化素、25(OH)D、T-P1NP、β-CTX水平与绝经后女性T2DM患者腰椎、股骨颈及全股骨的骨密度存在一定的相关性，可作为绝经后女性T2DM并发骨质疏松症的预测指标。
Abstract:
Objective　To investigate the correlation between serum chemokines,bone metabolic markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus (T2DM) and their predictive value for osteoporosis.Methods　A total of 321 postmenopausal women with T2DM admitted to Department of Endocrinology,Quanzhou First Hospital Affiliated to Fujian Medical University (Quanzhou Medical College Teaching Hospital) from September 2019 to June 2021 were selected as the research objects.The T value of bone mineral density of lumbar vertebrae,femoral neck and whole femur was measured by dual-energy X-ray bone densitometer,and the patients were divided into the normal bone density group (n=114),osteopenia group (n=117) and osteoporosis group (n=90) according to the T value.The clinical data including age,duration of diabetes and body mass index (BMI) of patients in the three groups were compared.The serum chemerin was quantitatively determined by double antibody sandwich enzyme-linked immunosorbent assay;the fasting blood glucose (FPG) was measured by glucose oxidase method;the level of glycosylated hemoglobin (HbA1c) was detected by high pressure liquid chromatography,and the levels of serum C-peptide (FCP),25-hydroxyvitamin D ［25 (OH) D］,parathyroid hormone (PTH),total bone type I procollagen N-terminal peptide (T-P1NP) and β-crosslaps(β-CTX) were measured by electrochemiluminescence.The correlation between the age,duration of diabetes,BMI,serum chemerin,bone metabolic markers and BMD of lumbar vertebrae,femoral neck and whole femur was analyzed by Person correlation analysis and multiple linear regression.Results　There was no significant difference in level of FPG,FCP,HbA1c and PTH of patients among the three groups(F=0.414,0.699,0.190,1.651,P>0.05).The age of patients in the osteoporosis group was significantly higher than that in the osteopenia group and normal bone density group (P<0.05);the duration of diabetes of patients in the osteoporosis group was significantly longer than those in the osteopenia group and normal bone density group (P<0.05);the levels of T-P1NP,β-CTX and serum chemerin were significantly higher than those in the osteopenia group and normal bone density group (P<0.05);the BMI and 25(OH)D level were significantly lower than those in the osteopenia group and normal bone density group (P<0.05).The age of patients in the osteopenia group was significantly higher than that in the normal bone density group (P<0.05);the duration of diabetes of patients in the osteopenia group was significantly longer than that in the normal bone density group (P<0.05);the levels of T-P1NP,β-CTX and serum chemerin were significantly higher than those in the normal bone density group (P<0.05);the BMI and 25(OH)D level were significantly lower than those in the normal bone density group (P<0.05).Pearson regression analysis showed that bone mineral density of lumbar was positively correlated with BMI and 25(OH)D (r=0.336,0.184;P<0.05),and it was negatively correlated with age,T-P1NP,β-CTX and serum chemerin (r=-0.594,-0.294,-0.489,-0.359;P<0.05).The bone mineral density of femoral neck was positively correlated with BMI and 25(OH)D (r=0.313,0.228;P<0.05),and it was negatively correlated with age,duration of diabetes,T-P1NP,β-CTX,serum chemerin (r=-0.577,-0.178,-0.223,-0.378,-0.336;P<0.05).The bone mineral density of whole femur was positively correlated with BMI and 25(OH)D (r=0.400,0.225;P<0.05),and it was negatively correlated with age,duration of diabetes,T-P1NP,β-CTX and serum chemerin (r=-0.487,-0.160,-0.235,-0.392,-0.373;P<0.05).Multiple linear regression analysis showed that the age,BMI,25(OH)D,T-P1NP and β-CTX were the factors affecting lumbar bone mineral density (β=-0.010,0.013,0.005,-0.001,-0.274;P<0.05).The age,duration of diabetes,BMI,25(OH)D,β-CTX and serum chemerin were the factors affecting femoral neck BMD (β=-0.008,-0.003,0.012,0.005,-0.152,-0.001;P<0.05).The age,duration of diabetes,BMI,25(OH)D,β-CTX and serum chemerin were the factors affecting the whole femur bone mineral density (β=-0.008,-0.004,0.019,0.006,-0.152,-0.001;P<0.05).Conclusion　The bone mineral density of postmenopausal women with T2DM decreased with age and the duration of diabetes mellitus;BMI was a protective factor of bone mineral density in postmenopausal women with T2DM;the serum chemerin and 25(OH)D,T-P1NP,β-CTX levels have a certain correlation with bone mineral density of lumbar vertebrae,femoral neck and whole femur in postmenopausal women with T2DM,those can be used as a predictor of postmenopausal women with T2DM complicated with osteoporosis.

参考文献/References:

［1］　《中国老年骨质疏松症诊疗指南》(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南(2018)［J］.中国骨质疏松杂志,2018,24(12):1541-1567.
WORKING GROUP ON GUIDELINES FOR DIAGNOSIS AND TREATMENT OF SENILE OSTEOPOROSIS IN CHINA (2018),OSTEOPOROSIS SOCIETY OF CHINA ASSOCIATION OF GERO-NTOLOGY AND GERIATRICS,MA Y Z,et al.2018 China guideline for diagnosis and treatment of senile osteoporosis［J］.Chin J Osteoporos,2018,24(12):1541-1567.
［2］　JAIN S,CAMACHO P.Use of bone turnover markers in the management of osteoporosis［J］.Curr Opin Endocrinol Diabetes Obes,2018,25(6):366-372.
［3］　YUE R,ZHOU B O,SHIMADA I S,et al.Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow［J］.Cell Stem Cell,2016,18(6):782-796.
［4］　黄文森,孙志纯,洪真真,等.2型糖尿病患者血清趋化素、non-HDL-C/HDL-C与微量白蛋白尿的相关性［J］.南京医科大学学报(自然科学版),2018,38(9):1259-1263.
HUANG W S,SUN Z C,HONG Z Z,et al.Correlation of serum chemerin and the non-HDL-C/ HDL-C ratio with microalbuminuria for patients with type 2 diabetes［J］.J Nanjing Med Univ (Nat Sci),2018,38(9):1259-1263.
［5］　MALANDISH A,TARTIBIAN B,SHEIKHLOU Z,et al.The effects of short-term moderate intensity aerobic exercise and long-term detraining on electrocardiogram indices and cardiac biomarkers in postmenopausal women［J］.J Electrocardiol,2020,60(3):15-22.
［6］　中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)［J］.中华糖尿病杂志,2021,13(4):315-409.
CHINESE DIABETES SOCIETY.Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)［J］.Chin J Diabetes Mellitus,2021,13(4):315-409.
［7］　CHELMO W,DAVI D,WITKO P,et al.Osteoporosis prevention,screening,and diagnosis:ACOG clinical practice guideline No.1［J］.Obstet Gynecol,2021,138(3):494-506.
［8］　COMPSTON J E,MCCLUNG M R,LESLIE W D.Osteoporosis［J］.Lancet,2019,393(10169):364-376.
［9］　POIANA C,CAPATINA C.Osteoporosis and fracture risk in patients with type 2 diabetes mellitus［J］.Acta Endocrinol (Buchar),2019,15(2):231-236.
［10］　XU H,WANG Z,LI X,et al.Osteoporosis and osteopenia among patients with type 2 diabetes aged≥50:role of sex and clinical characteristics［J］.J Clin Densitom,2020,23(1):29-36.
［11］　DE PAULA F J A,ROSEN C J.Structure and function of bone marrow adipocytes［J］.Compr Physiol,2017,8(1):315-349.
［12］　MURUGANANDAN S,GOVINDARAJAN R,MCMULLEN N M,et al.Chemokine-like receptor 1 is a novel Wnt target gene that regulates mesenchymal stem cell differentiation［J］.Stem Cells,2017,35(3):711-724.
［13］　RAMOS-JUNIOR E S,LEITE G A,CARMO-SILVA C C,et al.Adipokine chemerin bridges metabolic dyslipidemia and alveolar bone loss in mice［J］.J Bone Miner Res,2017,32(5):974-984.
［14］　SHI L,MAO C,WANG X,et al.Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women［J］.Medicine,2016,95(35):e4583.
［15］　GUO L,GAO Z,GE H.Effects of serum 25-hydroxyvitamin D level on decreased bone mineral density at femoral neck and total hip in Chinese type 2 diabetes［J］.PLoS One,2017,12(11):e0188894.
［16］　LIANG Y,LIU Y,LAI W,et al.1,25-dihydroxy vitamin D3 treatment attenuates osteopenia,and improves bone muscle quality in Goto-Kakizaki type 2 diabetes model rats［J］.Endocrine,2019,64(1):184-195.
［17］　GREGSON C L,ARMSTRONG D J,BOWDEN J,et al.UK clinical guideline for the prevention and treatment of osteoporosis［J］.Arch Osteoporos,2022,17(1):58.
［18］　CAMACHO P M,PETAK S M,BINKLEY N,et al.American assocition of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis［J］.Endocr Pract,2020,26(Suppl 1):1-46.
［19］　华仲森,陈之青.绝经后骨质疏松性腰椎骨折患者血清β-CTX、P1NP的水平及意义［J］.中国老年学杂志,2018,38(7):1642-1643.
HUA Z S,CHEN Z Q.Serum levels of β-CTX and P1NP in postmenopausal patients with osteoporotic lumbar fractures and their significance［J］.Chin J Gerontol,2018,38(7):1642-1643.
［20］　MOHSIN S,KAIMALA S,SUNNY J J,et al.Type 2 diabetes mellitus increases the risk to Hip fracture in postmenopausal osteoporosis by deteriorating the trabecular bone microarchitecture and bone mass［J］.J Diabetes Res,2019,2019:3876957.

相似文献/References:

[1]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[2]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[3]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[4]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[5]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[6]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[7]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[8]蒋铁桥,张群,杨刚毅,等.短期胰岛素泵强化治疗对初诊2型糖尿病患者β细胞功能的影响[J].新乡医学院学报,2010,27(04):000.
[9]王润之,黄艳群.LPIN1基因的研究进展[J].新乡医学院学报,2010,27(04):413.
[10]姥勇,屈阳,朱旅云,等.脂联素与2型糖尿病血管病变的关系[J].新乡医学院学报,2011,28(01):089.

更新日期/Last Update: 2022-11-05